Linni Fan

Dr. Linni Fan


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2023 in Science
Verified
Journal Article
Closed access
YZYue Zhai
Yue Zhai
LCLiang Chen
Liang Chen
QZQian Zhao
Qian Zhao
ZZZhao-Hui Zheng
Zhao-Hui Zheng
ZCZhinan Chen
Zhinan Chen
PZPing Zhu
Ping Zhu
Autoimmune diseases such as ankylosing spondylitis (AS) can be driven by emerging neoantigens that disrupt immune tolerance. Here, we developed a workflow to profile posttranslational modifications involved in neoantigen formation. Using mass spectrometry, we identified a panel of cysteine residues differentially modified by carboxyethylation that required 3-hydroxypropionic acid to generate neoantigens in patients with AS. The lysosomal degradation of integrin αIIb [ITGA2B (CD41)] carboxyethylated at Cys96 (ITGA2B-ceC96) generated carboxyethylated peptides that were presented by HLA-DRB1*04 to stimulate CD4 + T cell responses and induce autoantibody production. Immunization of HLA-DR4 transgenic mice with the ITGA2B-ceC96 peptide promoted colitis and vertebral bone erosion. Thus, metabolite-induced cysteine carboxyethylation can give rise to pathogenic neoantigens that lead to autoreactive CD4 + T cell responses and autoantibody production in autoimmune diseases.

17 October 2022 in Histopathology
Verified
Journal Article
Closed access
LYLi Yang
Li Yang
ZYZhiyong Yin
Zhiyong Yin
JWJie Wei
Jie Wei
JCJia Chai
Jia Chai
DZDanhui Zhao
Danhui Zhao
LFLinni Fan
Linni Fan

23 August 2022 in Pathology
Verified
Journal Article
Closed access
JCJia Chai
Jia Chai
JMJing Ma
Jing Ma
YLYixiong Liu
Yixiong Liu
DZDanhui Zhao
Danhui Zhao
ZYZhiyong Yin
Zhiyong Yin
LFLinni Fan
Linni Fan

10 January 2025 in Cancer Biology & Therapy
Verified
Journal Article
Open access
JMJing Ma
Jing Ma
YYYanru Yang
Yanru Yang
KWKaijing Wang
Kaijing Wang
JLJin Liu
Jin Liu
JFJunyi Feng
Junyi Feng
LFLinni Fan
Linni Fan
Ribosomal S6 protein kinase 4 (RSK4), a member of the serine‒threonine kinase family, plays a vital role in the Ras‒MAPK pathway. This kinase is responsible for managing several cellular activities, including cell growth, proliferation, survival, and mobility. In this study, we observed higher RSK4 protein expression in clear cell renal cell carcinoma (ccRCC) than in normal kidney tissue, and the overexpression of RSK4 might predict poor outcomes for ccRCC patients. Notably, renal cell carcinoma (RCC) is rich in blood vessels; therefore, this study aimed to explore the biological function of RSK4 in ccRCC progression and its specific regulatory mechanism. We analyzed changes in the expression of target genes through transcriptomic and proteomic assessments. We also conducted tube formation assays and VEGF ELISAs to understand the role of RSK4 in angiogenesis. Additionally, we evaluated the regulatory effect of RUNX1 on EPHA2 transcription using a luciferase reporter gene assay and observed that the effect of RUNX1 on activating EPHA2 transcription was negated after the binding site was mutated. Our findings suggested that RSK4 enhanced tube formation by stimulating VEGF secretion. Concurrently, in vivo experiments confirmed that RSK4 expedited RCC metastasis and angiogenesis. This evidence indicates that RSK4 may serve as a new prognostic marker and play a vital role in RCC metastasis.

19 June 2025 in European Journal of Nuclear Medicine and Molecular Imaging
Verified
Journal Article
Closed access
PDF file
XMXiaoli Meng
Xiaoli Meng
ZQZhiyong Quan
Zhiyong Quan
LFLinni Fan
Linni Fan
MZMingru Zhang
Mingru Zhang
GLGuiyu Li
Guiyu Li
FKFei Kang
Fei Kang

19 December 2022 in Frontiers in Oncology
Verified
Journal Article
Open access
JWJie Wei
Jie Wei
JWJianfeng Wu
Jianfeng Wu
ZYZhiyong Yin
Zhiyong Yin
XLXia Li
Xia Li
YLYixiong Liu
Yixiong Liu
LFLinni Fan
Linni Fan
Purpose: Chordoma is a rare and locally invasive neoplasm, and the prognostic factors are limited. Deregulation of Histone 3 lysine 27 (H3K27) trimethylation (H3K27me3) is considered to be related with poor prognosis in some tumors. The purpose of this study was to detect the expression of H3K27me3 in chordomas and analyze the correlation with clinicopathological features and explore the roles as potential prognostic markers and therapeutic targets.Material and method: Specimens of 162 chordoma patients (consisting of 156 conventional chordoma, 4 dedifferentiated chordoma and 2 poorly differentiated chordoma) were enrolled in a tissue microarray (TMA) in order to assess the immunohistochemical staining by H3K27me3 antibodies. Correlations between H3K27me3 expression and clinicopathological features were analyzed. Clinical data of the patients were correlated and survival analysis was performed. Kaplan-Meier survival curves and log-rank test were used to analyze the recurrence-free survival (RFS) and overall survival (OS). Multivariate Cox regression analyses were used to identify potential prognostic factors.Results: The expression of H3K27me3 was lower in 37 chordoma patients (37/162, 22.8%), and higher in 125 patients (125/162, 77.2%). H3K27me3-low expression significantly correlated with spine location (P < 0.001), conventional histological subtype (P < 0.001), and recurrence (P < 0.001). Log-rank test showed that H3K27me3-low expression was associated with poor RFS (P =0.027) and OS (P =0.009) in conventional chordoma patients. Cox multivariate analysis revealed that low expression of H3K27me3 was an independent predictor of poor OS (P =0.007) and RFS (P =0.025) in conventional chordoma patients.Conclusions: Our study indicates that low expression of H3K27me3 might be considered as a predictor for poor prognosis and recurrence, and it may provide a potential therapeutic target for conventional chordoma patients.